跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TARO-DICLOFENAC POTASSIUM POWDER FOR ORAL SOLUTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TARO-DICLOFENAC POTASSIUM POWDER FOR ORAL SOLUTION
Authorized
STANDARD
TARO-DICLOFENAC POTASSIUM POWDER FOR ORAL SOLUTION
Taro Pharmaceuticals Inc
🇨🇦 Health Canada
Approval Date
Aug 7, 2026
Approval ID
ce56de55a8cf851a
Company
Taro Pharmaceuticals Inc
Type
Standard
Approval Details
Approval Id
ce56de55a8cf851a
Drug Approval Canada Name
TARO-DICLOFENAC POTASSIUM POWDER FOR ORAL SOLUTION
Product Name
TARO-DICLOFENAC POTASSIUM POWDER FOR ORAL SOLUTION
Status
Approved
Status Date
2026-04-15
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Oral
Schedule
PRESCRIPTION
Atc Original
M01AB05 DICLOFENAC
Aig Number
0122516001
Company Name
Taro Pharmaceuticals Inc
Company Address
130 East Drive Brampton Ontario Canada L6T 1C1
Company Detail Path
/organization/taro-pharmaceuticals-inc
Company Information
Pharmaceutical Company Name
Taro Pharmaceuticals Inc
Country Name
Canada
Province Name
Ontario
City Name
brampton,ontario,country_ca
Address
130 East Dr
Active Ingredients
DICLOFENAC POTASSIUM
50 MG / SACHET
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Aug 7, 2026
Approval ID
ce56de55a8cf851a
Type
Standard
Back to Health Canada Approvals
